David W. Ghesquiere

David has served as senior vice president, Corporate & Business Development for NanoString since November 2013.

Before joining NanoString, David was the founder and managing director of Adrenaline Venture and Advisory LLC, an international advisory firm. Before founding the advisory firm, David served as senior vice president of Corporate and Business Development at Dendreon Corporation. David has also held various executive positions at OSI Pharmaceuticals, which Astellas Pharma acquired.

David received an MBA from the University of Western Ontario’s Ivey School of Business and a BA in Economics from the University of Western Ontario.